NIAID Emerging and Re-emerging Infectious Diseases NIAID Bioinformatics Resource Centers NIAID Structural Genomic Centers Center for Structural Genomics of Infectious Disease
Seattle Structural Genomics Center for Infectious Disease

MysmA.00184.a: 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase

Target Characteristics

from organism: Mycobacterium smegmatis ATCC 700084 / mc(2)155
most recent status: purified
center reference id: MysmA.00184.a
is community request: False
associated disease:
NIH risk group: 2
is select agent: False
NIH priority
pathogens category:
IIIC

Ordering Clones & Proteins

If there are materials available for this target, they will be listed below. Materials can be ordered from SSGCID using the button in the "order material" column. Clicking the button will add the material to a virtual cart. You may order multiple materials at a time at no cost to you, as this contract is funded by NIAID. When you are ready to place your order, click the "Place Order" link which will appear in the top right corner of the page after you place your first item in your cart.

Clones*

CENTER
REFERENCE ID
DOMAIN/REGION
DESCRIPTION
INFO AA
START
AA
STOP
ORDER
MATERIAL
MysmA.00184.a.A1.GE28576 Full length( MysmA.00184.a ) 1 247 GE28576
* SSGCID clones represent un-induced expression constructs which have been verified by sequencing from vector primers. Clones may contain a tag, such as N-term 6xHis. Get sequence information using the button in the "info" column.

Proteins

CENTER
REFERENCE ID
DOMAIN/REGION
DESCRIPTION
INFO AA
START
AA
STOP
ORDER
MATERIAL
MysmA.00184.a.A1.PS00553 Full length( MysmA.00184.a ) 1 247

External Resources

Resource Reference ID
OrthoMCL: OG5_127491
PATRIC ID: fig|246196.19.peg.925
RefSeq: YP_885338.1
UniProt: A0QR00

Enzyme & Pathway Information

Pathway Pathway ID EC Number
5.4.2.1
homolactic fermentation ANAEROFRUCAT-PWY 5.4.2.11
glycolysis III (from glucose) ANAGLYCOLYSIS-PWY 5.4.2.11
glycolysis I (from glucose 6-phosphate) GLYCOLYSIS 5.4.2.11
superpathway of glycolysis and the Entner-Doudoroff pathway GLYCOLYSIS-E-D 5.4.2.11
superpathway of glycolysis, pyruvate dehydrogenase, TCA, and glyoxylate bypass GLYCOLYSIS-TCA-GLYOX-BYPASS 5.4.2.11
superpathway of hexitol degradation (bacteria) HEXITOLDEGSUPER-PWY 5.4.2.11
heterolactic fermentation P122-PWY 5.4.2.11
superpathway of N-acetylneuraminate degradation P441-PWY 5.4.2.11
hexitol fermentation to lactate, formate, ethanol and acetate P461-PWY 5.4.2.11
formaldehyde assimilation I (serine pathway) PWY-1622 5.4.2.11
glycolysis II (from fructose 6-phosphate) PWY-5484 5.4.2.11
gluconeogenesis III PWY66-399 5.4.2.11
glycolysis VI (metazoan) PWY66-400 5.4.2.11
superpathway of anaerobic sucrose degradation PWY-7345 5.4.2.11

Sequences

These sequences are the native gene sequence; sequences of constructs derived from these sequences may differ due to codon optimization or other protocols. To find the specific sequence of any material you may have ordered, click on the "more" button next to the name of that material.
AA Sequence
MATLILLRHG ESQWNEKNLF TGWVDVDLTD KGRAEAVRGG QLMAEQGVLP DVLYTSLLRR AITTAHLALD AADRLWIPVH RDWRLNERHY GALQGLDKAE TKEKYGEEQF MAWRRSYDTP PPPIEKGSKY SQDADPRYAD IDGGPLTECL KDVVERFVPY YESAILPDLK AGKTVLIAAH GNSLRALVKY LDGMSDEEVV GLNIPTGIPL RYDLDENLKP VKIGGEYLDP EAAAAGAAAV AAQGAKK

NT Sequence
ATGGCGACCC TGATCCTGCT CCGCCACGGT GAGAGCCAGT GGAACGAGAA GAACCTGTTC ACCGGTTGGG TGGACGTCGA CCTCACTGAC AAGGGCCGGG CCGAGGCCGT CCGCGGCGGC CAACTGATGG CCGAGCAGGG CGTCCTGCCC GACGTGCTCT ACACGTCACT GCTGCGCCGG GCCATCACCA CCGCGCACCT CGCGCTCGAC GCCGCTGACC GGCTGTGGAT CCCGGTGCAC CGCGACTGGC GGCTCAACGA GCGCCACTAC GGCGCGCTGC AGGGCCTGGA CAAGGCCGAG ACCAAGGAGA AGTACGGCGA AGAGCAGTTC ATGGCGTGGC GCCGCAGCTA CGACACCCCG CCGCCGCCCA TCGAGAAGGG CAGCAAGTAC AGCCAGGACG CCGATCCGCG CTACGCCGAC ATCGACGGCG GCCCGTTGAC CGAATGCCTC AAAGACGTCG TCGAGCGGTT CGTGCCGTAC TACGAGAGCG CGATCTTGCC CGATCTGAAG GCGGGCAAGA CCGTGCTGAT CGCCGCCCAC GGCAACTCGC TGCGCGCGCT GGTGAAGTAC CTCGACGGCA TGTCCGACGA GGAGGTCGTC GGCCTCAACA TCCCGACCGG CATCCCGCTG CGCTACGACC TCGACGAGAA CCTCAAGCCC GTCAAGATCG GCGGTGAGTA CCTCGATCCC GAGGCGGCCG CCGCCGGTGC GGCCGCCGTC GCCGCCCAGG GCGCGAAGAA G

© 2020 Seattle Children's Research Institute. All rights reserved.